Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Use of Antiemetic Agents in Acute Gastroenteritis 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease
Your Article Summary
See Latest ArticlesNTBC therapy for tyrosinemia type 1: how much is enough
European Journal of Pediatrics, 11/04/09
El–Karaksy H et al. – Doses of NTBC, lower than recommended, may be helpful in treatment of tyrosinemia, on condition that succinylacetone production is suppressed, and AFP is maintained normal or showing a progressive decrease. This cost–effective dose may allow treatment of affected children from economically underprivileged countries, but longer follow up periods are needed.
Related Articles
Significant increase of succinylacetone within the first 12 h of life in hereditary tyrosinemia type 1
European Journal of Pediatrics, 10/13/09
Relevance Score: 80%
Today in Pediatrics...keeping you current
Receive free subspecialty "5-minute updates" via email
Blood in the stool raises concerns
The Clinical Advisor, 12/03/09
Coping and Severity of Behavioral Problems
Middle East Journal of Family Medicine, 12/03/09
Cardiopulmonary Resuscitation for Bradycardia With Poor Perfusion Versus Pulseless Cardiac Arrest
Pediatrics, 12/03/09
Sponsor
Article Search
Sponsor
Sponsor